Systems and methods for treating prostate cancer
A vapor delivery needle and method is provided that is adapted for treating prostate cancer. The energy delivery probe can apply condensable vapor energy to tissue, such as a peripheral zone tissue in a human prostate. In one method, a needle is introduced into peripheral zone tissue of a human prostate, and vapor media is delivered through the needle to ablate peripheral zone tissue without ablating non-peripheral zone tissue. Systems for treating prostate cancer with vapor therapy are also provided.
1. A method of treatment, the method comprising:
inserting a vapor delivery needle into a peripheral zone lobe of a prostate;
using the vapor delivery needle, delivering a first flow of vapor into the peripheral zone lobe;
using the delivered vapor, ablating an entirety of the peripheral zone lobe; and
delivering a second flow of vapor while withdrawing the vapor delivery needle from the prostate.
2. The method of claim 1 , wherein the delivered vapor is retained within a prostate capsule such that tissue outside of the prostate is not ablated.
3. The method of claim 1 , wherein the delivering the first flow of vapor step ablates only the peripheral zone lobe of the prostate.
4. The method of claim 1 , wherein the ablating step destroys cancerous, tissue in the peripheral zone lobe.
5. The method of claim 1 , wherein the vapor delivery needle includes a removable sheath having a pair of concentric tubes forming an insulating layer between the pair of concentric tubes, and wherein the sheath is tapered.
6. The method of claim 1 , further comprising measuring a temperature of the prostate.
7. The method of claim 6 , further comprising positioning a temperature probe exterior of the prostate.
8. The method of claim 6 , further comprising ceasing to deliver vapor when an exterior portion of the prostate reaches a temperature between 47 degrees C. and 52 degrees C.
9. The method of claim 1 , wherein the delivering the first flow of vapor step provides vapor for 20 seconds to 60 seconds.
10. A method of treatment, the method comprising:
inserting a vapor source into a tissue of a peripheral zone of a prostate, the tissue of the peripheral zone including a cancer lesion; and
using the vapor source, delivering an amount of vapor to the tissue of the peripheral zone, wherein the amount of vapor is configured to ablate all of the tissue comprising the peripheral zone of the tissue, and wherein the vapor is delivered while a needle of the vapor source is moving.
11. The method of claim 10 , wherein the delivered vapor is retained within a prostate capsule such that tissue outside of the prostate is not ablated.
12. The method of claim 10 , wherein the delivering the vapor step ablates only the peripheral zone of the prostate.
13. The method of claim 10 , wherein the vapor source includes a vapor delivery needle, the vapor delivery needle including a removable sheath having a pair of concentric tubes forming an insulating layer between the pair of concentric tubes, and wherein the sheath is tapered.
14. The method of claim 10 , further comprising measuring a temperature of the prostate.
15. The method of claim 14 , further comprising positioning a temperature probe exterior of the prostate.
16. The method of claim 14 , further comprising ceasing to deliver vapor when an exterior portion of the prostate reaches a temperature between 47 degrees C. and 52 degrees C.
17. The method of claim 14 , wherein delivery of the vapor while the needle is moving occurs while the needle is being withdrawn from the prostate.
18. The method of claim 10 , wherein the delivering the vapor step provides vapor for 20 seconds to 60 seconds.
19. A method of treatment, the method comprising:
inserting a vapor delivery needle into a peripheral zone lobe of a prostate;
while moving the vapor delivery needle, delivering a first amount of vapor into the peripheral zone lobe from the vapor delivery needle;
using the delivered vapor, ablating an entirety of the peripheral zone lobe, wherein the delivered vapor is retained within a prostate capsule such that tissue outside of the prostate is not ablated; and
delivering a second amount of vapor while withdrawing the vapor delivery needle from the prostate.
20. The method of claim 19 , further comprising positioning a temperature probe exterior of the prostate and ceasing to deliver vapor when an exterior portion of the prostate reaches a temperature between 47 degrees C. and 52 degrees C.